Skip to main content

Jeffrey Cohen

Analyst

Investor

Analyst

Ladenburg Thalmann & Company

Equibles does not estimate personal net worth.

About Jeffrey Cohen

Jeffrey Cohen is recorded as Analyst at Investor, Analyst at Ladenburg Thalmann & Company and Board Member at Aspira Women's Health Inc. (AWHL) since January 1, 2025. The newest filing on record that lists Jeffrey Cohen as Board Member at Aspira Women's Health Inc. (AWHL) is dated April 11, 2025. Jeffrey Cohen has spoken on 4 earnings calls across 3 companies, most recently for Vericel Corp on July 30, 2026. Those appearances were for Nano-X Imaging Ltd. (NNOX), Vericel Corp (VCEL) and Fractyl Health, Inc. (GUTS). Aspira Women's Health Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other companies whose calls Jeffrey Cohen spoke on are classified in the Healthcare sector. Other leadership on record at Aspira Women's Health Inc. includes John Fraser (CEO and Board Member), Michael Buhle (CEO), Nicole Sandford (CEO and CFO) and 7 others.

Jeffrey Cohen on recent calls

“So, Just a couple, I did want to follow up on sales organization and back half and potential expansion. Could you talk about back half? Do you plan to add commercial folks, at least domestically, and then maybe talk about what preparations are being made in the UK from a commercial standpoint prior to launch?”
Analyst — Investor, Vericel Corporation Second Quarter 2026 Earnings Call ·
“Firstly, could you talk about the Telerad business? And you did call out customer retention, increased rates, and increased volumes. Could you kind of drill into that a little bit for our benefit as far as rates go and number of customers and volumes and utilization?”
Analyst — Ladenburg Thalmann & Company, Earnings conference call (announced in 6-K) ·
“And as a follow-up, could you maybe talk about any net material ads or changes to the IP portfolio in the past quarter, including both potentially Rejuva as well?”
Analyst — Ladenburg Thalmann & Company, Fractyl Health, Inc. Q1 FY2026 Earnings Call ·
“I'd like you to dive in a little further. So could you talk a little bit about your footprint and commercial organization, mainly related in the U.S. as far as teams that are direct sales organizations, and talk a little bit about how that works with your distribution channels in the U.S.?”
Analyst — Ladenburg Thalmann & Company, Q4 FY2025 Earnings conference call (announced in 6-K) ·

Affiliation history

  • Aspira Women's Health Inc. (AWHL)

    Board Member

    Proxy statement

    Current

    2025-01-01–present

    Last confirmed April 11, 2025

  • Investor

    Analyst

    Source not stated

    Current
  • Ladenburg Thalmann & Company

    Analyst

    Source not stated

    Current

Company network

Leadership on record at Aspira Women's Health Inc.

Recent activity